Selam Ogbagabriel

Activity of panitumumab alone or with chemotherapy in non-small cell lung carcinoma cell lines expressing mutant epidermal growth factor receptor

Daniel J. Freeman, Todd Juan, T. Bush, 2009, Molecular Cancer Therapeutics.

Securin is overexpressed in breast cancer

F. Waldman, S. Bose, M. Fernando, 2005, Modern Pathology.

Tumor penetration and epidermal growth factor receptor saturation by panitumumab correlate with antitumor activity in a preclinical model of human cancer

Daniel J. Freeman, Sameer Doshi, R. Radinsky, 2012, Molecular Cancer.